OL
REGN icon

OneFund LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

OneFund LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Sell
275
-3
-1% -$2.04K 0.1% 190
2026
Q1 		$216K Sell
278
-23
-8% -$17.6K 0.14% 134
2025
Q4 		$232K Buy
301
+17
+6% +$11.5K 0.14% 126
2025
Q3 		$160K Buy
284
+10
+4% +$5.65K 0.1% 172
2025
Q2 		$144K Buy
+274
New +$153K 0.1% 179
2024
Q4 		– Sell
-278
Closed -$292K – 131
2024
Q3 		$292K Buy
278
+2
+0.7% +$2.23K 0.3% 85
2024
Q2 		$290K Buy
276
+2
+0.7% +$1.94K 0.32% 83
2024
Q1 		$266K Sell
274
-10
-4% -$9.51K 0.32% 91
2023
Q4 		$249K Buy
+284
New +$234K 0.32% 95

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

OneFund LLC's REGN Position: Q2 2026 in Review

OneFund LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 1.1% in Q2 2026, selling an estimated $2.04K and leaving 275 shares worth $171K. The position accounts for 0.1% of the portfolio, ranked #190.

OneFund LLC first reported a position in REGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $292K in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • OneFund LLC held 275 shares of Regeneron Pharmaceuticals worth $171K as of Q2 2026.
  • OneFund LLC sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up 0.1% of OneFund LLC's portfolio in Q2 2026, its #190 holding.
  • OneFund LLC first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • OneFund LLC's Regeneron Pharmaceuticals position peaked at $292K in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.